Little Canada, MN, United States of America

Liming Ni

This inventor holds 1 USPTO granted patent. Top assignee: Georgia Tech Research Corporation. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Liming Ni. Retrieved from https://idiyas.com/inventor/liming-ni-41658egr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 25(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Liming Ni

Introduction

Liming Ni is an accomplished inventor based in Little Canada, Minnesota. He has made significant contributions to the field of chemistry, particularly in the development of novel compounds with therapeutic applications. His work focuses on the synthesis of peptidyl derivatives that have potential uses in medicine.

Latest Patents

Liming Ni holds a patent for "Basic α-aminoalkylphosphonate derivatives - Peptidyl derivatives of diesters of α-aminoalkylphosphonic acids with basic substituents, their use in inhibiting serine proteases with trypsin-like specificity and their roles as anti-inflammatory agents, anticoagulants, and anti-tumor agents." This patent highlights his innovative approach to creating compounds that can address various health issues.

Career Highlights

Liming Ni is associated with the Georgia Tech Research Corporation, where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on therapeutic strategies in treating diseases.

Collaborations

He has collaborated with notable colleagues, including James C Powers and Delwin S Jackson, who have contributed to his research endeavors.

Conclusion

Liming Ni's innovative work in the field of chemistry exemplifies the importance of research in developing new therapeutic agents. His contributions are paving the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…